Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes

BACKGROUND: Ovarian carcinomas presenting homologous recombination deficiency (HRD), which is observed in about 50% of cases, are more sensitive to platinum and PARP inhibitor therapies. Although platinum resistant disease has a low chance to be responsive to platinum-based chemotherapy, a set of pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: da Costa, Alexandre A. B. A., do Canto, Luisa M., Larsen, Simon Jonas, Ribeiro, Adriana Regina Gonçalves, Stecca, Carlos Eduardo, Petersen, Annabeth Høgh, Aagaard, Mads M., de Brot, Louise, Baumbach, Jan, Baiocchi, Glauco, Achatz, Maria Isabel, Rogatto, Silvia Regina
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503431/
https://ncbi.nlm.nih.gov/pubmed/31060523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5622-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars